- Basil, Maria C;
- Cardenas-Diaz, Fabian L;
- Kathiriya, Jaymin J;
- Morley, Michael P;
- Carl, Justine;
- Brumwell, Alexis N;
- Katzen, Jeremy;
- Slovik, Katherine J;
- Babu, Apoorva;
- Zhou, Su;
- Kremp, Madison M;
- McCauley, Katherine B;
- Li, Shanru;
- Planer, Joseph D;
- Hussain, Shah S;
- Liu, Xiaoming;
- Windmueller, Rebecca;
- Ying, Yun;
- Stewart, Kathleen M;
- Oyster, Michelle;
- Christie, Jason D;
- Diamond, Joshua M;
- Engelhardt, John F;
- Cantu, Edward;
- Rowe, Steven M;
- Kotton, Darrell N;
- Chapman, Harold A;
- Morrisey, Edward E
The human lung differs substantially from its mouse counterpart, resulting in a distinct distal airway architecture affected by disease pathology in chronic obstructive pulmonary disease. In humans, the distal branches of the airway interweave with the alveolar gas-exchange niche, forming an anatomical structure known as the respiratory bronchioles. Owing to the lack of a counterpart in mouse, the cellular and molecular mechanisms that govern respiratory bronchioles in the human lung remain uncharacterized. Here we show that human respiratory bronchioles contain a unique secretory cell population that is distinct from cells in larger proximal airways. Organoid modelling reveals that these respiratory airway secretory (RAS) cells act as unidirectional progenitors for alveolar type 2 cells, which are essential for maintaining and regenerating the alveolar niche. RAS cell lineage differentiation into alveolar type 2 cells is regulated by Notch and Wnt signalling. In chronic obstructive pulmonary disease, RAS cells are altered transcriptionally, corresponding to abnormal alveolar type 2 cell states, which are associated with smoking exposure in both humans and ferrets. These data identify a distinct progenitor in a region of the human lung that is not found in mouse that has a critical role in maintaining the gas-exchange compartment and is altered in chronic lung disease.